Neuraminidase inhibitors--the story behind the Cochrane review
- PMID: 19995813
- DOI: 10.1136/bmj.b5164
Neuraminidase inhibitors--the story behind the Cochrane review
Similar articles
-
The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.BMJ. 2010 Jan 13;340:c130. doi: 10.1136/bmj.c130. BMJ. 2010. PMID: 20071425 No abstract available.
-
Oseltamivir resistance: what does it mean clinically?Clin Infect Dis. 2009 Dec 15;49(12):1836-7. doi: 10.1086/648425. Clin Infect Dis. 2009. PMID: 19911972 No abstract available.
-
Global transmission of oseltamivir-resistant influenza.N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2. N Engl J Med. 2009. PMID: 19258250 No abstract available.
-
[Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].Dtsch Med Wochenschr. 2008 Jun;133(23):1259-64. doi: 10.1055/s-2008-1077250. Dtsch Med Wochenschr. 2008. PMID: 18509804 Review. German. No abstract available.
-
What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?BMJ. 2009 Dec 8;339:b5248. doi: 10.1136/bmj.b5248. BMJ. 2009. PMID: 19995814 Review. No abstract available.
Cited by
-
The importance of clinical trial data sharing: toward more open science.Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):238-40. doi: 10.1161/CIRCOUTCOMES.112.965798. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22438465 Free PMC article. No abstract available.
-
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.Emerg Infect Dis. 2016 Jun;22(6):949-55. doi: 10.3201/eid2206.151037. Emerg Infect Dis. 2016. PMID: 27191818 Free PMC article.
-
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews.Health Res Policy Syst. 2017 Nov 9;15(1):93. doi: 10.1186/s12961-017-0259-8. Health Res Policy Syst. 2017. PMID: 29121959 Free PMC article.
-
Access to regulatory data from the European Medicines Agency: the times they are a-changing.Syst Rev. 2012 Oct 30;1:50. doi: 10.1186/2046-4053-1-50. Syst Rev. 2012. PMID: 23110993 Free PMC article.
-
Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data.PLoS Med. 2013 Oct;10(10):e1001526. doi: 10.1371/journal.pmed.1001526. Epub 2013 Oct 8. PLoS Med. 2013. PMID: 24115912 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical